Management of Male Breast Cancer
Key Points
Key Points
In 2019, an estimated 2,670 new cases of breast cancer will be diagnosed among men in the United States, and about 500 men will die from breast cancer.
The lifetime risk of breast cancer is about 1:1000 for a man, whereas it is approximately 1:8 for a woman.
There are substantial knowledge gaps concerning the optimal management of breast cancer in men.
To date, approaches to treating men with breast cancer have been extrapolated largely from research conducted in women with breast cancer.
Treatment
...Treatment...
...one receptor-positive breast cance...
...with hormone receptor-positive breast cancer...
...treated with adjuvant endocrine therapy s...
...e completed five years of tamoxifen, have tolera...
...early-stage breast cancer should n...
...anced or metastatic, hormone receptor-positive, HE...
...velop recurrent metastatic, hormone re...
...ocrine therapy for men with advanced o...
...apy guided by HER2, PDL-1, PIK3CA, and germline...
...f endocrine therapy toxicity is similar to the a...
...erone/androgen supplementation should not be...
...ns should counsel patients about the sympto...
...al annual mammogram should be offered to m...
...nual mammogram may be offered to men with...
...I is not recommended routinely in men with a h...
...atients with breast cancer should be offer...
...mendations That Did Not Reach the...